Flushed With Cash, Moderna Expands Space, Went on Hiring Spree and Launches at Least Two Clinical Trials
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal
Boehringer Ingelheim Halts Two Phase III Trials for Lung Cancer Drug Gilotrif
pSivida (PSDV) Has Its Own Brexit, Consolidates U.K. Operations to Massachusetts HQ
Clinton Running Mate Tim Kaine Scrutinized for Private Plane Ride Provided by Teva (TEVA) Subsidiary
French-Based Firm Advanced Accelerator Applications Opens Up Shop in New Jersey, Plans to Hire
Celgene (CELG)'s Revlimid Fails to Extend Survival in Lymphoma Study
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank
Genmab A/S (GEN.CO), Johnson & Johnson (JNJ)'s Daratumumab Granted Breakthrough Tag by the FDA
FDA Green Lights AbbVie (ABBV) Once-Daily Viekira XR for Hepatitis C
Sanofi (SNY) to Create 40 Jobs at Irish Plant
Speculation Heats Up on Biogen (BIIB) as an Acquisition Target or Starting a Buying Spree
Abbott (ABT) Sales Rep in India Blames Company in Suicide Note
5 Biotech Stocks on the Brink of Breaking Out
400+ Women are Suing Drug Giant Merck & Co. (MRK) Over Unequal Pay
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA)
Bankrupt BIND Therapeutics (BIND) Reveals Two More Bidders Join Pfizer (PFE)'s Stalking Horse Bid
Bay Area Startup Tricida Nabs $55 Million Series C
See All News >
//-->